BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33220802)

  • 1. Intraarterial Chemotherapy for Liver Metastases.
    Connell LC; Kemeny NE
    Surg Oncol Clin N Am; 2021 Jan; 30(1):143-158. PubMed ID: 33220802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
    Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al.
    Judge SJ; Cho M; Gholami S
    Ann Surg Oncol; 2022 Nov; 29(12):7246-7247. PubMed ID: 35829800
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).
    Kusano M; Aoyama T; Okabayashi K; Hirata K; Tsuji Y; Nakamori S; Asahara T; Ohashi Y; Yoshikawa T; Sakamoto J; Oba K; Saji S
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S761-S766. PubMed ID: 30249900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase II study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer.
    Ogata Y; Matono K; Tsuda H; Ushijima M; Uchida S; Akagi Y; Shirouzu K
    PLoS One; 2015; 10(3):e0120064. PubMed ID: 25790229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
    Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
    Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).
    Lorenz M; Müller HH; Schramm H; Gassel HJ; Rau HG; Ridwelski K; Hauss J; Stieger R; Jauch KW; Bechstein WO; Encke A
    Ann Surg; 1998 Dec; 228(6):756-62. PubMed ID: 9860474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of regional chemotherapy: hepatic arterial infusion for metastatic liver tumors].
    Takahashi T; Misuta K; Masui H; Ike H; Ohki S; Shimada H
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2155-7. PubMed ID: 7944427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Tono T; Takahashi H; Nakano Y; Matsushita M; Ohzato H; Fukunaga M; Watanabe H; Kanoh Y; Yasue A; Okada K; Hata T; Iwazawa T; Matsui S; Yano H; Kinuta M; Okamura J; Monden T
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1826-9. PubMed ID: 11086422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases.
    Turley MC; Moore C; Creasy JM; Sharib J; Lan B; Thacker JKM; Migaly J; Zani S; Allen PJ; Mantyh CR; Lidsky ME
    J Gastrointest Surg; 2022 Apr; 26(4):764-771. PubMed ID: 34820727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.
    Lee HJ; Lee YS; Lee KW; Kim SY; Yoon CJ; Shin DY; Lee YG; Choi SY; Kang SG; Kang SB; Kim JH
    Korean J Intern Med; 2011 Mar; 26(1):82-8. PubMed ID: 21437167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
    Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
    Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
    Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.